Reprogramming somatic cells into stem cells.
Recent scientific achievements in cell and developmental biology have provided unprecedented opportunities for advances in biomedical research. The demonstration that fully differentiated cells can reverse their gene expression profile to that of a pluripotent cell, and the successful derivation and culture of human embryonic stem cells (ESCs) have fuelled hopes for applications in regenerative medicine. These advances have been put to public scrutiny raising legal, moral and ethical issues which have resulted in different levels of acceptance. Ethical issues concerning the use of cloned human embryos for the derivation of stem cells have stimulated the search for alternative methods for reversing differentiated cells into multi/pluripotent cells. In this article, we will review the present state of these reprogramming technologies and discuss their relative success. We also overview reprogramming events after somatic cell nuclear transfer (SCNT), as they may further instruct ex ovo strategies for cellular manipulation.
Alberio
Ramiro
R
School of Biosciences. University of Nottingham, Loughborough, NG2 5RD, UK. ramiro.alberio@nottingham.ac.uk
Campbell
Keith H
KH
Johnson
Andrew D
AD
D000818:Animals; D002454:Cell Differentiation; D065150:Cellular Reprogramming; D004261:DNA Replication; D005057:Eukaryotic Cells / Q000166:cytology*; D005260:Female; D005786:Gene Expression Regulation; D016678:Genome; D006801:Humans; D008297:Male; D053652:Nuclear Transfer Techniques; D039904:Pluripotent Stem Cells / Q000166:cytology*